General Announcement::UPDATE ON COVID-19 SITUATION IN THE GROUP'S MANUFACTURING DIVISION IN MALAYSIA

UPDATE ON COVID-19 SITUATION IN THE GROUP'S MANUFACTURING DIVISION IN MALAYSIA

The board of Directors (the "Board") of UG Healthcare Corporation Limited (the "Company" and together with its subsidiaries, the "Group") refers to the Company's announcements dated 28 June 2021 and 12 July 2021 (the "Previous Announcements"), and wishes to provide a further update on the Covid-19 situation in the Group's upstream manufacturing division located in Malaysia. Unless otherwise defined, all capitalised terms used herein shall have the same meanings ascribed to them in the Previous Announcements.

The EMCO imposed on the district of Seremban, Malaysia where the Group's upstream manufacturing division is located, has ended on 22 July 2021 as scheduled. The Group's manufacturing operations has therefore resumed on 23 July 2021 at 60% workforce capacity as mandated by the Malaysian government.

The employees' health, safety and well-being remain the Group's utmost priority, and the Group will continue to comply with stringent Covid-19 prevention and control measures in its operations.

The Group will continue to monitor the evolving Covid-19 situation closely, and update shareholders on material developments as and when they arise.

By Order of the Board

UG Healthcare Corporation Limited

Lee Keck Keong

Executive Director and CEO

23 July 2021

This announcement has been reviewed by the Company's Sponsor, SAC Capital Private Limited (the "Sponsor").

This announcement has not been examined or approved by the Singapore Exchange Securities Trading Limited ("SGX-ST") and the SGX-ST assumes no responsibility for the contents of this announcement, including the correctness of any of the statements or opinions made or reports contained in this announcement.

The contact person for the Sponsor is Ms Charmian Lim (Telephone no.: (65) 6232 3210) at 1, Robinson Road, #21-00 AIA Tower, Singapore 048542.

Page 1 of 1